Update on Comprehensive Test Ban, & More from CRS
The Congressional Research Service has prepared an updated account of the status of the comprehensive nuclear test ban treaty (CTBT), which would prohibit explosive testing of nuclear weapons.
“As of August 2016, 183 states had signed the CTBT and 164, including Russia, had ratified it. However, entry into force requires ratification by 44 states specified in the treaty, of which 41 had signed the treaty and 36 had ratified.” The U.S. has not ratified it.
The Senate Foreign Relations Committee will hold a hearing on the CTBT tomorrow, September 7.
See Comprehensive Nuclear-Test-Ban Treaty: Background and Current Developments, September 1, 2016.
Other new and updated products from the Congressional Research Service include the following.
Climate Change: Frequently Asked Questions about the 2015 Paris Agreement, September 1, 2016
U.S. Textile Manufacturing and the Proposed Trans-Pacific Partnership Agreement, September 1, 2016
Comparing DHS Component Funding, FY2017: Fact Sheet, September 2, 2016
OPM Announces Premium Increase in the Federal Long-Term Care Insurance Program, CRS Insight, September 1, 2016
The European Union’s Small Business Act: A Different Approach, September 1, 2016
Zika Response Funding: Request and Congressional Action, updated September 1, 2016
The U.S. should continue its voluntary moratorium on explosive nuclear weapons tests and implement further checks on the president’s ability to call for a resumption of nuclear testing.
To help protect U.S. critical infrastructure workers, the next presidential administration should ensure ample supplies of high-quality respiratory personal protective equipment.
As data fuels the next transformative modernization phase, the federal government has an opportunity to leverage modern practices to leap forward in scaling IT modernization.
To maximize the potential of apprenticeship programs, the federal government should develop a cohesive approach to supporting “apprenticeships of the future,” such as those in cyber, healthcare, and advanced manufacturing.